These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 27462466)
41. Ring finger protein 126 (RNF126) suppresses ionizing radiation-induced p53-binding protein 1 (53BP1) focus formation. Lee NS; Chang HR; Kim S; Ji JH; Lee J; Lee HJ; Seo Y; Kang M; Han JS; Myung K; Kim Y; Kim H J Biol Chem; 2018 Jan; 293(2):588-598. PubMed ID: 29167269 [TBL] [Abstract][Full Text] [Related]
43. Cytosolic quality control of mislocalized proteins requires RNF126 recruitment to Bag6. Rodrigo-Brenni MC; Gutierrez E; Hegde RS Mol Cell; 2014 Jul; 55(2):227-37. PubMed ID: 24981174 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of Pyruvate Dehydrogenase Kinase as a Therapeutic Strategy against Cancer. Sradhanjali S; Reddy MM Curr Top Med Chem; 2018; 18(6):444-453. PubMed ID: 29788890 [TBL] [Abstract][Full Text] [Related]
45. MicroRNA-133b/EGFR axis regulates esophageal squamous cell carcinoma metastases by suppressing anoikis resistance and anchorage-independent growth. Zhu JF; Liu Y; Huang H; Shan L; Han ZG; Liu JY; Li YL; Dong X; Zeng W Cancer Cell Int; 2018; 18():193. PubMed ID: 30479571 [TBL] [Abstract][Full Text] [Related]
46. Nematode pyruvate dehydrogenase kinases: role of the C-terminus in binding to the dihydrolipoyl transacetylase core of the pyruvate dehydrogenase complex. Chen W; Komuniecki PR; Komuniecki R Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):103-9. PubMed ID: 10085233 [TBL] [Abstract][Full Text] [Related]
47. Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis. Woolbright BL; Rajendran G; Harris RA; Taylor JA Mol Cancer Ther; 2019 Oct; 18(10):1673-1681. PubMed ID: 31511353 [TBL] [Abstract][Full Text] [Related]
49. Tumor cell-derived exosome RNF126 affects the immune microenvironment and promotes nasopharyngeal carcinoma progression by regulating PTEN ubiquitination. Yu C; Xue B; Li J; Zhang Q Apoptosis; 2022 Aug; 27(7-8):590-605. PubMed ID: 35717659 [TBL] [Abstract][Full Text] [Related]
50. Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis. Ferrarini MG; Nisimura LM; Girard RMBM; Alencar MB; Fragoso MSI; Araújo-Silva CA; Veiga AA; Abud APR; Nardelli SC; Vommaro RC; Silber AM; France-Sagot M; Ávila AR mSphere; 2021 Jan; 6(1):. PubMed ID: 33408226 [TBL] [Abstract][Full Text] [Related]
51. Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications. Wang X; Shen X; Yan Y; Li H Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33739396 [TBL] [Abstract][Full Text] [Related]
52. Loss of anchorage primarily induces non-apoptotic cell death in a human mammary epithelial cell line under atypical focal adhesion kinase signaling. Ishikawa F; Ushida K; Mori K; Shibanuma M Cell Death Dis; 2015 Jan; 6(1):e1619. PubMed ID: 25611393 [TBL] [Abstract][Full Text] [Related]
54. An indispensable role of TAZ in anoikis resistance promoted by OTUB1 deubiquitinating enzyme in basal-like triple-negative breast cancer cells. Nakagawa H; Higurashi M; Ishikawa F; Mori K; Shibanuma M Biochem Biophys Res Commun; 2023 Mar; 649():1-9. PubMed ID: 36738577 [TBL] [Abstract][Full Text] [Related]
55. Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells. Uehara N; Matsuoka Y; Tsubura A Mol Cancer Res; 2008 Feb; 6(2):186-93. PubMed ID: 18245228 [TBL] [Abstract][Full Text] [Related]
56. Targeting the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis to discover potent PDK inhibitors through structure-based virtual screening and pharmacological evaluation. Gan L; Yang Y; Liang Z; Zhang M; He Y; Zhang SL Eur J Med Chem; 2024 Jan; 264():116008. PubMed ID: 38056298 [TBL] [Abstract][Full Text] [Related]
57. Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer. Nunes-Xavier CE; Mingo J; Emaldi M; Flem-Karlsen K; Mælandsmo GM; Fodstad Ø; Llarena R; López JI; Pulido R Front Oncol; 2022; 12():873516. PubMed ID: 35692804 [TBL] [Abstract][Full Text] [Related]
58. Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology. Sutendra G; Michelakis ED Front Oncol; 2013; 3():38. PubMed ID: 23471124 [TBL] [Abstract][Full Text] [Related]
59. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway. Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517 [TBL] [Abstract][Full Text] [Related]
60. Acquisition of anoikis resistance promotes alterations in the Ras/ERK and PI3K/Akt signaling pathways and matrix remodeling in endothelial cells. de Sousa Mesquita AP; de Araújo Lopes S; Pernambuco Filho PCA; Nader HB; Lopes CC Apoptosis; 2017 Sep; 22(9):1116-1137. PubMed ID: 28653224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]